Abstract:Cathepsin K (Cat-K) highly expressed in osteoclasts, is considered to be a promising target for osteoclast-related maladies. In the present study, quantitative structure–activity relationships (QSAR) and molecular docking approaches were used to identify promising Cat-K inhibitors from a series of Amide-Ac6-aminoacetonitriles analogs. During the two-dimensional QSAR study, the statistical model PLS_MDL was chosen (r2 = 0.823, q2 (cross-validation) = 0.732). Descriptors with positive or negative contributions were derived from model PLS_MDL. In order to build robust three-dimensional QSAR models, three different molecular fingerprints were used as analysis precepts for clustering and three different minimization algorithms were employed for generation of molecular poses. The best database which used molecular fingerprint of FCFP and minimization algorithm of Smart Minimizer was selected for further QSAR model construction. The ideal CoMFA and CoMSIA models were acquired (CoMFA: r2 = 0.963, q2 = 0.674, r2pred = 0.702 and Q2 (F2) = 0.616; CoMSIA_SEHA: r2 = 0.989, q2 = 0.622, r2pred = 0.719 and Q2 (F2) = 0.638). Physicochemical, structural, electrostatic, and steric properties were derived from the created QSAR models and then applied to portray a design scheme. Furthermore, after a selecting of docking scheme, docking studies were carried out to measure the binding affinity of eligible query compounds and to reveal the detailed interactions between ligand and the target protein. Amongst these designed compounds, compound19OX32 was focused for its preferable predicted activity and docking score. Strong interactions and extra hydrogen bonds which echoed the previous summarized design scheme were also observed via a deep investigation of docking result. Consequently, compound 19OX32 was identified as promising Cat-K inhibitor.

Inhibitors of Cathepsins K and S Identified Using the DynaMAD Virtual Screening Algorithm

Highly Selective Aza-Nitrile Inhibitors for Cathepsin K, Structural Optimization and Molecular Modeling

Deciphering Cathepsin K inhibitors: a combined QSAR, docking and MD simulation based machine learning approaches for drug design

Integrated machine learning-based virtual screening and biological evaluation for identification of potential inhibitors against cathepsin K

Advances in Cathepsin S Inhibition: Challenges and Breakthroughs in Drug Development

A Combined approach of QSAR study, molecular docking and pharmacokinetics prediction of promising Amide-Ac6-aminoacetonitriles Cathepsin K inhibitors

Discovery and Computational Studies of Potent Covalent Kinase Inhibitors with alpha-Substituent Electrophiles Targeting Cysteine

Discovery and Computational Studies of Potent Covalent Kinase Inhibitors with -Substituent Electrophiles Targeting Cysteine

Interactions of a Low Molecular Weight Inhibitor from Streptomyces sp. MBR04 with Human Cathepsin D: Implications in Mechanism of Inactivation

Identification of novel potential cathepsin-B inhibitors through pharmacophore-based virtual screening, molecular docking, and dynamics simulation studies for the treatment of Alzheimer's disease

Computer-assisted Discovery and Evaluation of Potential Ribosomal Protein S6 Kinase Beta 2 Inhibitors

Novel selective proline-based peptidomimetics for human cathepsin K inhibition

An approach combining deep learning and molecule docking for drug discovery of cathepsin L

Substituted 4H-3,1-benzoxazine-4-one Derivatives as Inhibitors of Cathepsin G

Probing the Activity Modification Space of the Cysteine Peptidase Cathepsin K with Novel Allosteric Modifiers

Repurposed pharmacotherapy: targeting cathepsin L with repurposed drugs in virtual screening

New inhibitors of cathepsin V impair tumor cell proliferation and elastin degradation and increase immune cell cytotoxicity

Novel structural features of CDK inhibition revealed by an ab initio computational method combined with dynamic simulations

Use of protease substrate specificity screening in the rational design of selective protease inhibitors with unnatural amino acids: Application to HGFA, matriptase, and hepsin

Synthesis and evaluation of chemical linchpins for highly selective CK2α targeting

Cinnamaldehyde hydrazone derivatives as potential cathepsin B inhibitors: parallel in-vitro investigation in liver and cerebrospinal fluid